. Author manuscript; available in PMC: 2019 Oct 30.

Published in final edited form as: Sci Transl Med. 2018 Jan 24;10(425):eaam6354. doi: 10.1126/scitranslmed.aam6354

Table 1.

Characteristics of the CAPRISA 004 study population

Variable	Cases (n=59) Median (IQR)	Controls (n=106) Median (IQR)	P value
Age^*	23 (20, 25)	22 (20, 28)	.864
Urban site	19/59 (32.2)	40/106 (37.7)	.503
TFV arm^*	23/59 (39.0)	43/106 (40.6)	.87
DMPA use	50/59 (84.7)	85/106 (80.2)	.532
Vaginal discharge	25/59 (42.4)	35/106 (33.0)	.242
Ulcers	1/59 (1.7)	6/106 (5.7)	.423
HSV-2 sero-status (at trial entry)	32/59 (54.2)	53/106 (50.0)	.629
Sex acts, past 30 days	5 (2.5, 6.6)	5 (3, 8)	.281
Parity	1 (1, 2)	1 (1, 1)	.878

Part of the matching criteria